Pediatrica lands $28M Series B to widen access to pediatric care
What's the deal? Pediatrica Health Group has raised US$18.1M Series B round led by Valspring CapitalDealroom has a profile for this one. Try Dealroom →, with participation from existing investor M33 GrowthDealroom has a profile for this one. Try Dealroom →. The Miami- and Boston-based company runs multi-site pediatric primary care clinics and plans to use the funds for organic growth and acquisitions.
What's the endgame? Pediatrica wants to expand equitable access to pediatric primary care, including for underserved families. The money will also fund clinical and operational infrastructure, technology, and its value-based care capabilities.
Where's it growing? The company has reached 21 locations across Florida and Texas since its founding with M33. The new capital is earmarked for more locations and providers.
Why now? The round follows a period of rapid expansion that Pediatrica says proved out its model. "Our partnership with M33 gave us the runway to prove our model," said Roberto PalenzuelaDealroom has a profile for this one. Try Dealroom →, adding the raise lets the company "reach more children, more communities."
Who's backing it? Valspring focuses on growth-stage healthcare services companies. "Pediatrica reflects our thesis that lasting change in healthcare is driven by companies that innovate on the patient and provider experience to deliver better outcomes," said Yumin Choi, managing partner at Valspring.
M33, the founding investor, remains active in the company's strategy. "From day one, we believed in Roberto's vision for a better pediatric care experience," said Gabe LingDealroom has a profile for this one. Try Dealroom →, founder of M33.
The signal: At $28 million, the round sits in the top quintile of funding deals by size, a notable sum for a specialised primary care operator. It reflects continued investor appetite for value-based healthcare models that pair provider experience with broader patient access.
Image credit: juhansonin
